Recent results from the Phase III NRG-RTOG 1112 clinical study showed that the addition of stereotactic body radiotherapy (SBRT) to systemic therapy with sorafenib significantly improved progression-free survival (PFS) and time-to-progression in patients with locally advanced hepatocellular carcinoma (HCC) when compared to sorafenib alone.
‘Critically Impactful’ Drug Shortages; Emotions and Cancer; CRC Clues in Microbiome
In a recent survey, almost a third of healthcare system pharmacists said drug shortages are “critically impacting” patient care. (CNN) Six months of aerobic exercise
August 11, 2023